MALAT1 and breast cancer: This demonstrates that the integration of lncRNA to an mRNA signature could improve the prognosis value, as was also demonstrated for the combinatorial use of lncRNA MALAT1 and Oncotype Dx, for predicting the diagnosis of early-stage breast cancer [122].